论文部分内容阅读
哮喘是一种复杂的炎症性疾病,其病理特征为长期的气道炎症和气道的高反应性(AHR),而气道变应性炎症是哮喘临床症状和气道高反应性的基础,多种细胞因子和炎症介质参与了哮喘发生发展过程。T细胞及其分泌的各种炎症因子在哮喘中起到非常重要的调控作用,即调节Th1/Th2型细胞之间的平衡成为治疗哮喘免疫的热点之一[1]。其中血浆白细胞介素6(IL-6)、IL-8和γ-干扰素(IFN-γ)是Th1和Th2细胞
Asthma is a complex inflammatory disease characterized by long-term airway inflammation and airway hyperresponsiveness (AHR), while airway allergic inflammation is the basis of clinical symptoms and airway hyperresponsiveness in asthma Cytokines and inflammatory mediators are involved in the development of asthma. T cells and their secretion of various inflammatory cytokines play a very important regulatory role in asthma, that is, the balance between Th1 / Th2-type cells becomes one of the hot spots for the treatment of asthma immunity [1]. Among them, plasma interleukin 6 (IL-6), IL-8 and interferon-γ (IFN-γ) are Th1 and Th2 cells